Ferronova has developed a low-toxicity, non-invasive technology for the rapid and accurate tracing and visualisation of the pathways of spread of cancer to lymph nodes. The technology is designed to provide a more accurate mapping of these systems, a more detailed assessment of primary tumour pathology, and is designed to enable the detection of micro-metastasis and other isolated tumours which can be missed in traditional diagnostic methods.

Developed from research at Victoria University of Wellington and the University of South Australia, this in-depth, holistic diagnosis approach is designed to better dictate a patient’s treatment pathway. With ongoing support from Aotearoa New Zealand researchers and investors, Ferronova has a strong patent portfolio and network of research partners across Australasia.